Public-registry site landscape for NCT04203901, a Advanced Renal Cell Carcinoma study sponsored by CoImmune. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04203901 (registry record) |
| Sponsor | CoImmune |
| Condition(s) | Advanced Renal Cell Carcinoma |
| Phase | PHASE2 |
| Listed sites | 9 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04203901 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →